Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41


Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.

Kalpana G, Figy C, Yeung M, Yeung KC.

Sci Rep. 2019 Nov 8;9(1):16351. doi: 10.1038/s41598-019-52746-w.


Determinants of life satisfaction and self-perception of ageing among elderly people in China: An exploratory study in comparison between physical and social functioning.

Pan Y, Chan SHW, Xu Y, Yeung KC.

Arch Gerontol Geriatr. 2019 Sep - Oct;84:103910. doi: 10.1016/j.archger.2019.103910. Epub 2019 Jul 8.


Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells.

Datar I, Kalpana G, Choi J, Basuroy T, Trumbly R, Chaitanya Arudra SK, McPhee MD, de la Serna I, Yeung KC.

PLoS One. 2019 Apr 17;14(4):e0204387. doi: 10.1371/journal.pone.0204387. eCollection 2019.


Correction: RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.

Datar I, Qiu X, Ma HZ, Yeung M, Aras S, de la Serna I, Al-Mulla F, Tan TZ, Thiery JP, Trumbly R, Xuan F, Cui H, Yeung KC.

Oncotarget. 2016 May 3;7(18):26925. doi: 10.18632/oncotarget.9139.


RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.

Datar I, Qiu X, Ma HZ, Yeung M, Aras S, de la Serna I, Al-Mulla F, Thiery JP, Trumbly R, Fan X, Cui H, Yeung KC.

Oncotarget. 2015 Nov 17;6(36):39050-61. doi: 10.18632/oncotarget.5176. Erratum in: Oncotarget. 2016 May 3;7(18):26925.


RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.

Datar I, Feng J, Qiu X, Lewandowski J, Yeung M, Ren G, Aras S, Al-Mulla F, Cui H, Trumbly R, Arudra SK, De Las Casas LE, de la Serna I, Bitar MS, Yeung KC.

PLoS One. 2015 Aug 26;10(8):e0134494. doi: 10.1371/journal.pone.0134494. eCollection 2015.


Genetic and epigenetic control of RKIP transcription.

Datar I, Tegegne H, Qin K, Al-Mulla F, Bitar MS, Trumbly RJ, Yeung KC.

Crit Rev Oncog. 2014;19(6):417-30. Review.


Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.

Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC, Keller ET.

Prostate. 2015 Feb 15;75(3):292-302. doi: 10.1002/pros.22915. Epub 2014 Oct 18.


Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.

Yousuf S, Duan M, Moen EL, Cross-Knorr S, Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E, Chatterjee D.

PLoS One. 2014 Mar 21;9(3):e92478. doi: 10.1371/journal.pone.0092478. eCollection 2014.


Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

Al-Mulla F, Bitar MS, Thiery JP, Zea TT, Chatterjee D, Bennett L, Park S, Edwards J, Yeung KC.

Am J Cancer Res. 2013 Nov 1;3(5):446-64. eCollection 2013.


SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.

Marathe HG, Mehta G, Zhang X, Datar I, Mehrotra A, Yeung KC, de la Serna IL.

PLoS One. 2013 Jul 16;8(7):e69037. doi: 10.1371/journal.pone.0069037. Print 2013.


RKIP: much more than Raf kinase inhibitory protein.

Al-Mulla F, Bitar MS, Taqi Z, Yeung KC.

J Cell Physiol. 2013 Aug;228(8):1688-702. doi: 10.1002/jcp.24335. Review.


Diastereoselective ruthenium porphyrin-catalyzed tandem nitrone formation/1,3-dipolar cycloaddition for isoxazolidines. Synthesis, in silico docking study and in vitro biological activities.

Reddy AR, Guo Z, Siu FM, Lok CN, Liu F, Yeung KC, Zhou CY, Che CM.

Org Biomol Chem. 2012 Dec 14;10(46):9165-74. doi: 10.1039/c2ob26518d. Epub 2012 Sep 11.


A Micro-RNA Connection in BRaf(V600E)-Mediated Premature Senescence of Human Melanocytes.

Ren G, Feng J, Datar I, Yeung AH, Saladi SV, Feng Y, de la Serna I, Yeung KC.

Int J Cell Biol. 2012;2012:913242. doi: 10.1155/2012/913242. Epub 2012 Apr 24.


Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.

Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I, Yeung KC.

Cancer Res. 2012 Jun 15;72(12):3091-104. doi: 10.1158/0008-5472.CAN-11-3546. Epub 2012 Apr 13.


Measuring safety climate in elderly homes.

Yeung KC, Chan CC.

J Safety Res. 2012 Feb;43(1):9-20. doi: 10.1016/j.jsr.2011.10.009. Epub 2012 Feb 11.


A new model for raf kinase inhibitory protein induced chemotherapeutic resistance.

Al-Mulla F, Bitar MS, Feng J, Park S, Yeung KC.

PLoS One. 2012;7(1):e29532. doi: 10.1371/journal.pone.0029532. Epub 2012 Jan 18.


Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G.

Cancer Lett. 2010 Dec 28;299(2):137-49. doi: 10.1016/j.canlet.2010.08.012. Epub 2010 Sep 19.


RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex.

Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC.

FEBS Lett. 2010 Feb 19;584(4):662-8. doi: 10.1016/j.febslet.2009.12.051. Epub 2009 Dec 30.


The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.

Rath O, Park S, Tang HH, Banfield MJ, Brady RL, Lee YC, Dignam JD, Sedivy JM, Kolch W, Yeung KC.

Cell Signal. 2008 May;20(5):935-41. doi: 10.1016/j.cellsig.2008.01.012. Epub 2008 Jan 24.


Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.

Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC.

Oncogene. 2008 Apr 3;27(15):2243-8. Epub 2007 Oct 22.


Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.

Mc Henry KT, Montesano R, Zhu S, Beshir AB, Tang HH, Yeung KC, Fenteany G.

J Cell Biochem. 2008 Feb 15;103(3):972-85.


Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit.

Theroux S, Pereira M, Casten KS, Burwell RD, Yeung KC, Sedivy JM, Klysik J.

Brain Res Bull. 2007 Mar 30;71(6):559-67. Epub 2006 Dec 11.


Regulation of RKIP binding to the N-region of the Raf-1 kinase.

Park S, Rath O, Beach S, Xiang X, Kelly SM, Luo Z, Kolch W, Yeung KC.

FEBS Lett. 2006 Nov 27;580(27):6405-12. Epub 2006 Nov 3.


An innovation in drug prevention programs for adolescents: the Hong Kong Astro project.

Lam CW, Shek DT, Ng HY, Yeung KC, Lam DO.

Int J Adolesc Med Health. 2005 Oct-Dec;17(4):343-53.


RKIP downregulates B-Raf kinase activity in melanoma cancer cells.

Park S, Yeung ML, Beach S, Shields JM, Yeung KC.

Oncogene. 2005 May 12;24(21):3535-40.


RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis.

Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC.

J Biol Chem. 2004 Apr 23;279(17):17515-23. Epub 2004 Feb 6.


Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position.

Hindley AD, Park S, Wang L, Shah K, Wang Y, Hu X, Shokat KM, Kolch W, Sedivy JM, Yeung KC.

FEBS Lett. 2004 Jan 2;556(1-3):26-34.


Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM.

Mol Cell Biol. 2001 Nov;21(21):7207-17.


Evaluation of the value of an observation ward in an emergency department.

Yeung KC, Wong TW, Chan R, Lau CC.

Eur J Emerg Med. 1999 Mar;6(1):49-53.


Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class II gene transcription.

Yeung KC, Inostroza JA, Mermelstein FH, Kannabiran C, Reinberg D.

Genes Dev. 1994 Sep 1;8(17):2097-109.


A K pi =8(-) isomer in 136Sm.

Bruce AM, Walker PM, Regan PH, Dracoulis GD, Byrne AP, Kibèdi T, Lane GJ, Yeung KC.

Phys Rev C Nucl Phys. 1994 Jul;50(1):480-482. No abstract available.


Supplemental Content

Loading ...
Support Center